MCRNA - Overview: Chlamydia trachomatis, Miscellaneous Sites, Nucleic Acid Amplification, Varies
Detecting Chlamydia trachomatis in non-US Food and Drug Administration-approved specimen types This test is not intended for use in medico-legal applications. This test is not useful for the detection of Chlamydia pneumoniae or other...
DSM5X - Overview: Drugs of Abuse Screen 5, Chain of Custody, Meconium
Identifying amphetamines (and methamphetamines), opiates, phencyclidine, as well as metabolites of cocaine and marijuana in meconium specimens Chain of custody is required whenever the results of testing could be used in a court of law....
STRNG - Overview: Strongyloides Antibody, IgG, Serum
Screening for the presence of IgG-class antibodies to Strongyloides This test is not useful for monitoring patient response to therapy as IgG-class antibodies to Strongyloides may remain detectable following resolution of infection.
AKC - Overview: Adenylate Kinase Enzyme Activity, Blood
Assessment of adenylate kinase activity as part of the evaluation of chronic nonspherocytic hemolytic anemia
ALFP - Overview: Alpha-Fetoprotein (AFP) Immunostain, Technical Component Only
Aiding in the identification of yolk sac tumors and hepatocellular carcinoma
HQ - Overview: HemoQuant, Feces
Detection of blood in feces Evaluation of iron deficiency Detection of bleeding as a complication of anticoagulant therapy and other medication regimens This test is not specific for bowel cancer.
FENTS - Overview: Fentanyl, Serum
Monitoring fentanyl therapy
FLUOX - Overview: Fluoxetine, Serum
Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance
OXCO1 - Overview: Oxalate, Random, Urine
Monitoring therapy for kidney stones Identifying increased urinary oxalate as a risk factor for stone formation Diagnosis of primary or secondary hyperoxaluria
PCPMC - Overview: Phencyclidine (PCP) Confirmation, Meconium
Detection of in utero to phencyclidine (PCP) exposure up to 5 months before birth
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....